Onyda XR (clonidine ER, non-stimulant ADHD)
ADHD in pediatric patients 6 years and older, as monotherapy or adjunct to CNS stimulants. Child and adolescent psychiatry (ADHD).
About Onyda Xr
Onyda XR (clonidine hydrochloride extended-release oral suspension) is manufactured by Tris Pharma and was approved by the US FDA in 2024 for attention-deficit hyperactivity disorder (ADHD) in pediatric patients six years and older, as monotherapy or as adjunct to a CNS stimulant. It is the first FDA-approved liquid extended-release clonidine for paediatric ADHD.
The molecule is a central alpha-2 adrenergic agonist that modulates presynaptic noradrenergic activity. It is a non-stimulant and is not a controlled substance; it is not an amphetamine and is not on any DEA schedule. Paediatricians often reach for clonidine ER precisely because they want an alpha-2 mechanism rather than a stimulant, with the liquid formulation supporting flexible weight-based titration in younger children. Onyda XR is typically dosed in the evening to support sleep onset and next-day attention.
Onyda XR may be accessible to international patients through Named Patient Program or personal-import pathways where it is not yet locally registered.
Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.
How Reserve Meds coordinates Onyda Xr
- Patient or treating physician submits a named-patient request.
- Clinical team verifies appropriateness of Onyda Xr for the patient and destination country.
- Treating physician issues prescription and clinical justification.
- Country-specific NPP / personal-import documentation is prepared.
- Onyda Xr is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
- Shipment is coordinated to the patient's physician or hospital pharmacy (cold-chain where required).
Access by country
Reserve Meds publishes a detailed country deep-dive for Onyda Xr in every market we coordinate. Each page below covers the destination-country regulatory pathway (named-patient framework), real costs in local currency and USD, indicative timelines, physician-credential requirements, and cold-chain handling for the route into that country. Tap any country to read the full deep-dive.
Start a request for Onyda Xr
Submit a 60-second intake. Our clinical team will reach out as our first cohort opens with case-specific feasibility, timeline, and a formal quote.